Cancer immunotherapy resistance: The impact of microbiome-derived short-chain fatty acids and other emerging metabolites
Authors:
- 22 April 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 300, 120573
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell HomeostasisScience, 2013
- Escherichia coli Nissle 1917 Targets and Restrains Mouse B16 Melanoma and 4T1 Breast Tumors through Expression of Azurin ProteinApplied and Environmental Microbiology, 2012
- AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of NotchNature Immunology, 2011
- Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteersThe ISME Journal, 2011
- Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Carcinogenicity of deoxycholate, a secondary bile acidArchives of Toxicology, 2011
- The Microbe-Derived Short Chain Fatty Acid Butyrate Targets miRNA-Dependent p21 Gene Expression in Human Colon CancerPLOS ONE, 2011
- Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in Apc
Min
/+
mice with natural ligandsProceedings of the National Academy of Sciences, 2009
- Deoxycholic acid induces the overexpression of intestinal mucin, MUC2, via NF-kB signaling pathway in human esophageal adenocarcinoma cellsBMC Cancer, 2008
- Adenosine A 2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector functionThe FASEB Journal, 2008